About us

Ignition Labs draws experience from a pool of mentors, each with entrepreneurial experience, skills and experience in the health & medical technology industry, or a significant health technology industry network.  Ignition Labs mentors get involved. They provide sage advice and get their hands dirty when projects need a boost. A mentor is married to each project, acting like a case manager to ensure you’re always headed in the right direction.

Our mentor pool is growing, keep an eye out for updates to this page.

Mentors 2013 – Health & Medtech

Dr Alan Taylor

Alan has a background in both investment banking and medical science. Alan has approximately 10 years of Investment Banking experience, and was until very recently an Executive Director and shareholder of Inteq Limited, a boutique Australian investment bank, where he remains on the Board of Directors. Alan has significant experience in capital raisings, both private as well as public raisings through initial public offerings (IPOs) and secondary raisings on the Australian Securities Exchange, experience in mergers and acquisitions, general corporate advisory, and debt finance, with a focus on small to medium sized companies. At Inteq, Alan was involved in two of Australia’s largest life sciences IPOs, Reva Medical and GI Dynamics, both of which raised more than $80 million each. He has experience across a broad range of industries including healthcare and life sciences, technology, and resources. Prior to entering investment banking, Alan ran his own consulting business in the healthcare area.  Alan completed an undergraduate degree in Applied Science at the University of Sydney, where he finished first in his year and won the prestigious University Medal. He then completed his Ph.D. in Medicine at the Garvan Institute of Medical Research, where he investigated the molecular mechanisms of skeletal muscle insulin resistance. Alan has also completed a Graduate Diploma in Applied Finance at the Securities Institute of Australia.

Adrian Bunter

Adrian is a Director at Hall Capital and has over 16 years’ experience in providing consulting, due diligence, audit, taxation and corporate finance experience to private, listed and public sector clients. This experience has covered businesses across a wide range of industries.  Prior to joining Hall Capital, Adrian was a Director at PricewaterhouseCoopers in the Private Clients and then Mergers & Acquisitions groups. Adrian has had significant experience in advising clients on commercial, business management and strategic issues covering all facets of their business. Adrian has strong skills in looking at business and operational issues faced by clients, whilst ensuring the financial and value building requirements of the client are met.  Adrian’s mergers and acquisition and other corporate finance transaction experience has covered the full spectrum of business life cycles ranging from early stage start-up companies, through to business expansion and ultimately to the final business sale. Generally, Adrian has worked on transactions ranging in value from several million dollars to $150m+.

Andrew Stead

Andrew is a co-founder of both Ignition Labs and Sydney Angels.  He is the Director of New Ventures at NICTA and the former Director of Business Development at ATP Innovations, Australia’s largest community of technology entrepreneurs.  Andrew also lectures in entrepreneurship at the University of Sydney.  Andrew adds successes like the sale of a search technology to Google to his 15 years experience in the global information technology and telecommunications sector. 
Andrew has a Bachelor of Science (Hons) from the University of Sydney, an MBA from the Macquarie Graduate School of Management, is a graduate of the Royal Military College Sandhurst, is a member of the Australian Institute of Company Directors (GAICD) and was awarded a Churchill Fellowship in 2009.

Ben Wright

Ben is a co-founder of the Ignition Labs Seed Accelerator and the Director of Commercial Development at ATP Innovations, a facilitated innovation ecosystem.  He has worked in and on start-ups for more than 13 years and has held both research and management positions, gaining significant experience in research & development, clinical trials, business development, operations, and the financial management of both private and ASX listed biotechnology and medical device companies. Ben plays an active role in steering businesses  from focus on research & development to market validation, product manufacture and launch. Ben has a Bachelor of Science (Biological Sciences) from the University of Western Sydney and a Graduate Diploma of Biomedical Engineering from the University of New South Wales.

Brian Dorricott

Brian has extensive experience of starting, developing and selling businesses in the security and messaging sectors of the IT industry. After completing a Masters in Engineering at Imperial College, he worked for Philips and Logica before setting up two companies: DeeZee Ltd and Gordano Ltd. Brian was the Architect and Managing Director of DeeZee in 1997 when it sold to CISCO Systems Inc. He was the Founder, Architect and Managing Director of Gordano Ltd from 1994 until 2003 when the company was sold to the existing management team. Gordano software products have been purchased by over 20,000 companies in over 120 countries around the world including Telstra, Fuiji Film, University of Toronto, IBM, TieRack, Marks & Spencer, Oxfam, Dolby, NASA Space Goddard Center, US Army, Cable & Wireless and Barclays Bank. After leaving Gordano, Brian travelled to the four corners of the earth before becoming the Network Manager for the Bristol based Business Angel Network SWAIN (South West Angel and Investor Network). After leaving SWAIN, Brian has continued his work as an Entrepreneur in Residence for SETSquared and UWE, and established his consultancy firm, Meteorical, which provides training to mentors and investors to help them be more successful with their investments in small, start-up businesses.

Carla Stern

Carla is an entrepreneur with hands-on business development experience in life sciences/ biotechnology, and non-profit sector practices. After studying molecular genetics at the University of New South Wales, Carla worked as the Pathology Core Coordinator in Boston at the Brigham and Women’s Hospital. Carla the attained an MBA at MIT Sloan before returning to Brigham as a Pre-Doctoral Fellow. Carla joined the MIT Sloan admission committee and now manages her own Project Consulting business, Stern & Associates.

Craig Lawn

Craig is a partner at PricewaterhouseCoopers and has been directly involved in providing income tax and commercial advice for over 29 years. He has been responsible for advising research organisations, venture capital and IIF funds, CRCs and life science and technology based companies, advising on strategy and structure, R&D, and global expansion including licensing, tax rollovers, withholding tax, gearing and capital. His client experience includes many CRC’s, CSIRO, UQ, Innovation Capital, QRx Pharma, Cardno Engineering, Peplin Biotech Ltd, Resmed Ltd, Baxter Healthcare, Sonic Healthcare, One Ventures, Innovation Capital and Allen & Buckeridge. Craig leads the Sydney Private Clients Service practice with over 220 people focused on private companies and high net worth individuals.
Professional Memberships: ICAA
Education: Bachelor of Economics Law, University of Sydney

David Barda

David is an entrepreneur, executive and advisor specialising in technology commercialisation and early stage ventures. Originally qualified with a Bachelor of Science in Computer Science from UNSW, David first worked in technical and research roles before taking on investment advisory positions with professional and private investor firms focusing on techonology based startups. In 1997, David founded and was Managing Director of IF Media, a publishing venture launched to take advantage of generational technology developments in the film and TV industry. David was awarded an AFI award in 2000 for his contribution to the industry. David was also the founding CEO, director and long term CTO of Simavita which is commercialising a world first continence monitoring technology for residential aged care where he managed research, product design and development, Intellectual property, business strategy and corporate development. In 2009, David completed a Masters of Intellectual Property through Monash University. Over the last 18 months, David has been advising Saluda Medical in relation to strategy and raising $15m in new funds as part of their spin-out from NICTA. Saluda Medical is commercialising a ground-breaking device for the treatment of chronic pain, a new spinal cord stimulator which comprises closed loop feedback control.  David also runs his own consultancy and corporate advisory firm which helps startups with the funding strategy, IP strategy and financial management.

David Jones

David is a serial internet company founder who previously started SurfControl Email Filter (now WebSENSE), SpamMATTERS and ThreatMetrix – now a Gartner “Visionary” company for Web Fraud Protection. Each of these companies filter large amounts of “big-data” to provide value to customers – StreetHawk’s “RRR Matching Engine” continues the tradition. In his copious spare time (not) David can be found freezing in Freshwater ocean pool, mangling mandarin and aiding the Australian startup scene via initiatives like StartMate and now Ignition Labs. David has a keen interest in the quantified self, connected devices space.

Dr George Margelis

George is a medical practitioner who has been deeply involved in technology for the last 30 years. Originally trained as an optometrist, George started tinkering with computers in the early 80’s when he bought his first PC and has been incorporating medicine and technology ever since. Working on projects in hospital and community care he has been at the forefront of the use of technology. During that time he has remained a staunch supporter of participatory medicine, with a strong focus on building communications between healthcare providers and consumers. In the last decade George has been a major proponent for the use of enhanced communications between doctors and health consumers and has played a major role in the development of Your Diagnosis, an online tool for health consumers to better understand their health issues, as well as Your Health Record, a personal health record introduced in 2003. George was the former General Manager Australia at Care Innovations, an Intel GE joint venture, and is an active health policy blogger and speaker at local and international events like TED and Health 2.0. George was appointed Adjunct Associate Professor at the University of Western Sydney in June 2103.

Dr Greg Roger, MB BS ME

Founder of biomedical engineering services company Cryptych, Dr Greg Roger, has more than 25 years experience in the field of medicine, bio-medical engineering, product development and commercialisation. Having developed, patented and commercialised medical devices Dr Roger is familiar with the key issues of this industry for individuals through to larger corporations. Dr Roger founded and led Advanced Surgical Design and Manufacture Ltd for 17 years, culminating in its listing on the ASX in 2007. Dr Roger retired from ASDM Ltd in 2012. Since 2003 Dr Roger has taught bio-engineering at the University of Sydney, where he holds the post of Adjunct Associate Professor. During this period, Dr Roger has also conducted and supervised research at all levels. Dr Roger has worked with government agencies, including the TGA, at Federal and State levels in the field of medical device expert committees, grant giving authorities and advisory boards.

Hamish Hawthorn

Hamish Hawthorn is a co-founder of Ignition labs and the Chief Executive Officer at ATP Innovations, Australia’s leading technology business incubator. Hamish has been involved in the commercialisation of technology for over 15 years and worked in the advanced manufacturing, IT and life sciences sectors. In late 2008, Hamish co-founded Sydney Angels, a Sydney-based Angel group that invests in early stage high growth companies. 

Hamish is a Visiting Fellow in the Entrepreneurs in Science Program at the University of New South Wales, and lectures on entrepreneurship at the University of Sydney, the University of Technology, Sydney and the Australian National University. He is a qualified mechanical engineer with postgraduate training in business and technology.

Malcolm Hebblewhite

Malcolm is an entrepreneur with over 20 years of technical and international business experience in telecommunications and medical device product design, development, sales, and marketing.  Malcolm was a pre-IPO employee of ResMed (NYSE:RMD), where he started as an engineer in product development and R&D. He subsequently held executive roles in business development, marketing and M&A for ResMed over a ten-year period across three continents. Malcolm also held engineering and project management roles with Nokia Mobile Phones, developing personal mobile communications products. He is a named author on six international patents.  Malcolm is the founder of HC Partners, a management consultancy specialising in strategy creation and technology commercialisation.  Malcolm holds a degree in Aerospace Engineering with Honours from the University of NSW and an MBA from Kellogg.

Dr Matt Harris

Matt is the Executive Director of CIMTECH, Managing Director at Clarity Pharmaceuticals and Managing Director at TM Ventures. Matt has held leading managerial and Director positions in the Australian biotechnology industry including a pre-seed investment firm, an ASX listed biotechnology company and a start-up biopharmaceutical company. His achievements in industry are built upon a solid academic background. Matt was awarded a PhD in cancer research from the John Curtin School of Medical Research (ANU), an MBA and has held US and Australian academic fellowships.

Nic Lowe

Nic is a serial entrepreneur, co-founder and Director of Goget, a rapidly expanding car sharing business and an angel investor. Nic brings an in-depth knowledge of the sustainable business environment in Australia. With a Bachelor of Commerce (University of Western Australia) and a Masters of International Relations (University of Sydney), Nic worked in a number of banks where he traded various portfolios. One of Nic’s favourite quotes is “A good plan violently executed right now is far better than a perfect plan executed next week.”

Dr Peter Cronin

Dr Peter Cronin is the co-founder of Prospection, a health analytics and consulting company. Prospection has developed a big data platform called PharmDash and provides solutions to pharmaceutical and healthcare clients. Peter has previously founded, built and sold a healthcare recruitment business to an ASX listed company. He still works clinically in intensive care medicine and has over 10 years of experience in public and private hospital systems in Australia and New Zealand. He has degrees in medicine and technology and an MBA from AGSM.

Dr Peter Spencer

Peter currently runs a consulting business and has over 30 years’ experience in developing new medical products and companies across a range of technologies including medical devices, biotechnology, pharmaceuticals and consumer products. He has worked in the USA, Australia and Germany in a number of senior positions. These include Johnson and Johnson Inc (JNJ) for 14 years most recently as a Corporate Director in the USA with responsibility for sourcing and developing early stage external ventures for commercialisation by JNJ. His current and past roles involve non- executive board, CEO, COO, senior management and advisory positions in several start-up companies including Vasoproducts, Intraoptics, Warm Contact, AIMEDICS, Somnomed, Nanosonics, BCS International, Sonomedical and Maskmedic which have resulted in the successful commercialisation of a number of new products and enterprises. He was a cofounder in 2001 and NSW Group Chairman for a number of years of AUSMEDTECH (originally The Medical Device Network) which represents early stage Australian medical product companies. Peter has lectured in a number of University and Government sponsored innovation courses and programs and been involved as a panel assessor and advisor to academic innovation related funding programs including Cooperative Research Centres and the NHMRC Development Grant Scheme. He has academic qualifications including Bachelor of Science and Bachelor of Chemical Engineering (Hons 1) degrees from Sydney University, a PhD in Biomedical Engineering from UNSW and an Executive MBA (Honours Society) from Columbia University, New York.

Petra Andren

Petra is an experienced strategist and business developer with a strong passion and a natural flair for spotting and acting on business opportunities. She has a long and proven track record in successfully positioning/repositioning companies to achieve success in domestic and overseas markets. She has broad international work experience from holding senior strategy consulting, business development and executive roles in Europe, the US and Australia. She speaks multiple European languages and has worked for governments as well as the private sector as an advisor as well as an implementer of corporate strategy, opening up and developing new markets in different technology based areas in particular Life Sciences and IT. Petra is a member of the Australian Institute of Company Directors.

Reba Moyes

As the program manager for both Startmate and Ignition Labs Reba offers a unique perspective on seed accelerator programs and how to get the most out of them. She works with businesses in the ATP Innovations incubator on a daily basis and administers 66 Meetups in Sydney. Reba has a keen interest in the convergence of technology and a unique background in roles spanning manufacture and creative industries. From running her family business manufacturing hang gliders to working as part of a production team on fashion advertising shoots she draws on experience in project management, product development and manufacture, business development and establishing customer relationships to bring unique insights into business strategy. Reba holds a Bachelor of Medical Science and Diploma in Innovation Management from University of New South Wales.

Dr Rob Daniels

Robert is the CEO of Elastagen, a next generation cosmetics and medical treatments company.  Robert has successfully guided Elastagen from its early research phases through to the current clinical development of its Elastatherapy™ treatments for the rapidly growing cosmetic and medical dermatology markets. Prior to joining Elastagen Robert had spent the previous 10 years working across a broad range of the life science industry including contract research, medical devices and therapeutics. He has been successful in raising capital; managing in- and out- licensing programs; joint venture creation; and, managing product development programs through to the clinic. Robert’s experience includes University spin-outs through to listed companies; and, he has worked in the UK, Australia and Hong Kong. Most recently he was VP Asia Pacific for PharmaVentures Ltd, a boutique transaction advisory firm specialising in the life sciences. Prior to that Robert was Chief Commercial Officer at Novathera Ltd where he gained significant domain experience in the regenerative medicine field. Robert has a PhD from University College London and a Masters in Entrepreneurship and Innovation from the Australian Graduate School of Entrepreneurship.

Rui Rodrigues

Rui is a venture consultant, angel investor and high-octane engineer. After studying mechanical engineering in Portugal, Rui completed a MSc in France and an MBA at the London Business School. He is the former Technical and Commercialisation Director of the Portuguese Centre for Innovation and Creative Engineering, and was the Test Team Engine Chief Engineer for 7 years with the Lotus Renault Formula 1 Team. He also worked for a London-based venture capital fund, where he started investing in cleantech. Rui likes to get his hands dirty and work with crazy entrepreneurs to develop innovative businesses and technologies.

Stephen Thompson

Stephen Thompson is a founding partner of Brandon Capital Partners, an Australian life science venture fund manager. Before moving to Australia in 2004 he was a director with Apax Partners based in London and focused on early stage venture investing. Previously he worked with a UK biotechnology company, Cantab Pharmaceuticals, following 10 years of medical research in London and California. Stephen has a BSc and PhD in immunology and an MBA. He is a director of Elastagen Pty Ltd, MiReven Pty Ltd, Vaxxas Pty Ltd and the Cancer Therapeutics CRC.

Professor Steven Boyages

Steven is currently the Medical Director for eHealth NSW and CEO of media marketing & PR company Red Zeppelin. Previously Steven was the Foundation Chief Executive of the Clinical Education and Training Institute (CETI) of NSW. Steven was formerly the Chief Executive of the Sydney West Area Health Service (SWAHS) and has professorial appointments to the University of Sydney and the University of Western Sydney.  Steven is a unique hybrid of clinician manager who continues to work in the clinical field of endocrinology. He was previously the Director of Diabetes and Endocrinology at Westmead Hospital from 1990 to 1999. In that role his major achievements were to define the pathophysiology of thyroid hormone deficiency on brain development secondary to iodine deficiency; to develop prevention strategies in iodine deficient communities in China, India, Indonesia and Northern Italy; to define the impact of Growth Hormone excess and deficiency in adults and to develop innovative population health models of care for people with diabetes. Steven continues an active research career in a range of domains, but mostly in the pursuit of better models of chronic disease prevention and management.  Steven’s current interests are varied and include the application of health technology to health care delivery, in particular the development of IT applications that add value to the enterprise, to the community and to the patient. Steven’s teams have developed sophisticated web based business information tools that allow real time enterprise monitoring.

Stuart Fox

Stuart is a professional investor and a member of the Sydney Angels network. Stuart is involved in a portfolio of investments that span property, software and fashion. Stuart is involved in with the University of Wollongong, Financial Services Institute of Australasia and Opportunity International. Stuart was formerly the Managing Director, Head of Commodities at Asia UBS AG.

 


Program Sponsors

Griffith_Hack Logo
Griffith Hack is a national leader in providing intellectual property services to medical technology companies. The group comprises a specialised team of intellectual property attorneys and lawyers who are at the forefront of protecting, managing, enforcing and commercialising clients’ innovations in this highly sophisticated healthcare field. Our professionals are experienced in working closely with companies to develop effective patent strategies which both protect their innovative technologies and permit them to commercialise their technology without infringing the rights of others.

Griffith Hack has been named IP Specialist Firm of the Year by Australasian Legal Business (ALB) for three years running (2011, 2012 and 2013) and have committed to providing Ignition Labs 2013 portfolio businesses with in-kind IP services to the value of $2000 per company as well as working with each business in a mentoring capacity. For more information on Griffith Hack visit www.griffithhack.com.au

 

UKTI_CMYK_AW

UK Trade & Investment (UKTI) is the commercial arm of the British Government. UKTI helps the best and most innovative overseas companies to look at the UK as their global partner of choice. By partnering with ATP Innovations on the Ignition Labs programme, UKTI will be able to provide practical help and expertise to medtech companies in Australia. The UK Medical Technology industry has grown rapidly over the last 4 years, with turnover of medical technologies companies increasing by 50% between 2009-2012 and the number of people employed in the sector rising by 40%. With a buoyant medical industry and the British economy returning to consistent growth, now is a great time for Australian medical technology companies to be exploring the UK market.

The UK is building an integrated health economy which offers a powerful combination of world-class universities and research facilities. The UK has an established manufacturing and supply chain as well as world class translational research infrastructure and clinical networks. With a supportive business environment, generous incentives for R&D, and unrivalled, clinically-coded health data and bioresources, the UK offers medical technology companies a world class platform to innovate and enjoy global growth.

Find out more about UK Trade & Investment and see how we can help your business.

British_Airways_Logo_small
British Airways, a full service global airline and partner in the award winning Oneworld® Alliance, is possibly the world’s most innovative commercial carrier. British Airways has a progressive vision that saw the implementation of the worlds first fully flat bed in business class to the introduction of the “On Business” corporate loyalty program in 2010. On Business is a unique loyalty program that accumulates points for company travel that can be redeemed for tangible travel benefits.

In early 2013 BA announced the first of it’s “UnGrounded” innovation lab flights. 130 tech-illuminati participated in the 11-hour hack between San Francisco and London at 30,000 feet before presenting their ideas on bridging the gap between science, technology, engineering and mathematics (STEM) to the United Nations at the Decide Now Act (DNA) Summit in London.

Partnering with ATP Innovations on the Ignition Labs Health and Medical Technology Accelerator is an extension of this progressive vision and reinforces the airlines commitment to Australian businesses through On Business. British Airways will fly qualifying Ignition Labs applicants from 5 health and medtech startups to London, UK, in November to attend Health 2.0 as part of the program.

For more information on the British Airways On Business program please
visit www.ba.com/onbusiness

Brandon Capital

Brandon Capital Partners makes seed and venture capital investments to support the development and international growth of Australian life science companies. Brandon Capital work collaboratively with entrepreneurs to demonstrate the benefit of their technology, thereby creating value for them, their teams and our investors.  For more information about Brandon Capital Partners, please visit www.brandoncapital.com.au.

 


Corporate Founder

Ignition Labs has pedigree. The seed accelerator operates within ATP Innovations, Australia’s leading business incubator.

Since 2006 ATP Innovations has worked with more than 80 businesses. These companies have:

▪ Raised over $80 million from private investors.
▪ Secured more than $18 million of competitive government grants.
▪ Filed 240 patents and trademarks applications with 94 granted.
▪ 6 portfolio companies were acquired.

In 2010 ATP Innovations was involved in Australia’s first seed accelerator, Startmate, a highly successful ICT program that resulted in significant follow-on funding for its business portfolio. ATP Innovations continues to support the Startmate initiative and builds on its success with Australia’s niche seed accelerator, Ignition Labs.

The Ignition Labs seed accelerator was founded in 2012 by the team at ATP Innovations, Australia’s leading deep technology incubator.  Ignition Labs Program 1 focused on clean technologies that enhanced the use of renewable resources or decreased the use of finite resources.  Five teams were selected from the applicant pool and completed the 3-month accelerator program in October 2012.  Highlights from Ignition Labs Cohort 1 include a hydrogen generation technology company on the cusp of closing a significant angel investment round, a collaborative consumption company that recently signed a multi-site community trial with one of Australia’s largest property developers and an electric vehicle company deemed so cool, Audi approached them to star in an advertisement for the launch of the Audi Q5 in Australia.

The ATP Innovations executive team has extensive experience in developing early stage businesses, excellent life science credentials and the skills required for successful business incubation. The team is complemented by the inclusion of Australian and US mentors, whose close industry connections and experience at developing start-up businesses will be leveraged to multiply success within the accelerators health & medtech portfolio.


Mentors 2012 – Cleantech

Adrian Bunter

Adrian is a Director at Hall Capital and has over 16 years’ experience in providing consulting, due diligence, audit, taxation and corporate finance experience to private, listed and public sector clients. This experience has covered businesses across a wide range of industries.  Prior to joining Hall Capital, Adrian was a Director at PricewaterhouseCoopers in the Private Clients and then Mergers & Acquisitions groups. Adrian has had significant experience in advising clients on commercial, business management and strategic issues covering all facets of their business. Adrian has strong skills in looking at business and operational issues faced by clients, whilst ensuring the financial and value building requirements of the client are met.  Adrian’s mergers and acquisition and other corporate finance transaction experience has covered the full spectrum of business life cycles ranging from early stage start-up companies, through to business expansion and ultimately to the final business sale. Generally, Adrian has worked on transactions ranging in value from several million dollars to $150m+.

Stuart Fox

Stuart is a professional investor and a member of the Sydney Angels network.  Stuart is involved in a portfolio of investments that span property, software and fashion.  Stuart is involved in with the University of Wollongong, Financial Services Institute of Australasia and Opportunity International.  Stuart was formerly the Managing Director, Head of Commodities at Asia UBS AG

Ivor Frischknecht

Ivor was appointed as the CEO for Australian Renewable Energy Agency (ARENA)  in August 2012.  Ivor brings his experiences as Investment Director of Starfish Ventures Pty Ltd to the mentor pool.  Starfish is a venture capital firm that manages $400 million primarily on behalf of Australian superannuation funds.  Ivors’s key activities included responsibility for the firm’s cleantech investment activities, including for alternative energy, water and other environmental technologies.  He was previously Director of New Ventures, Idealab, a company involved in developing and investing in technology start-up companies, including renewable energy companies, and was also the CEO of H2onsite (a company involved in commercialisation of clean energy generation technology) and a senior executive and advisor to a range of venture capital and energy companies.  Ivor holds a Bachelor of Laws and Bachelor of Economics with Honours from the University of Sydney and a Masters of Business Administration and Public Management Certificate from Stanford University’s Graduate School of Business.

Matt Harris

Matt is the Executive Director of CIMTECH, Managing Director at Clarity Pharmaceuticals and Managing Director at TM Ventures.  Matt has held leading managerial and Director positions in the Australian biotechnology industry including a pre-seed investment firm, an ASX listed biotechnology company and a start-up biopharmaceutical company.  His achievements in industry are built upon a solid academic background. Matt was awarded a PhD in cancer research from the John Curtin School of Medical Research (ANU), an MBA and has held US and Australian academic fellowships.

Hamish Hawthorn

Hamish Hawthorn is a co-founder of Ignition labs and the Chief Executive Officer at ATP Innovations, Australia’s leading technology business incubator. Hamish has been involved in the commercialisation of technology for over 15 years and worked in the advanced manufacturing, IT and life sciences sectors. In late 2008, Hamish co-founded Sydney Angels, a Sydney-based Angel group that invests in early stage high growth companies. 

Hamish is a Visiting Fellow in the Entrepreneurs in Science Program at the University of New South Wales, and lectures on entrepreneurship at the University of Sydney, the University of Technology, Sydney and the Australian National University. He is a qualified mechanical engineer with postgraduate training in business and technology.

Richard Horton

Richard is a partner at DLA Piper focusing on clean technology development and deployment (system construction and power sale) projects, strategic intellectual property advice (both transactional and litigation), and private and venture financing and M&A transactions, representing US, Australian and offshore multinationals throughout the US, Europe and the Asia-Pacific region. He is admitted to practice in both California and Australia and actively advises clients under both US and Australian law. Before joining DLA Piper, he spent 3 years as a partner in the San Francisco office of Minter Ellison and 5 years in the technology and corporate group of Skadden, Arps, Slate, Meagher & Flom. Prior to leaving Australia, Richard was a senior associate in the Sydney office of Mallesons Stephens Jaques and spent 12 months on secondment with Australia’s dominant telecommunications company, Telstra Corporation. Richard speaks regularly before the Licensing Executives Society, the Practicing Law Institute, the IP Society, and the Computer Law Association (now iTech Law) and has lectured at various universities.

Bruce Jeffries

Bruce is a co-founder and Director of Goget.  Following involvement with the Masters program at Murdoch University Institute for Sustainability and Technology Policy, Bruce has worked extensively in both the private and government sectors. He has recently been an integral part of the NSW State Government’s Sustainability Unit, based within the NSW Department of Infrastructure, Planning and Natural Resources.

Nic Lowe

Nic is a co-founder and Director of Goget, a rapidly expanding car sharing business.

Nic brings an in-depth knowledge of the sustainable business environment in Australia. With a Bachelor of Commerce (University of Western Australia) and a Masters of International Relations (University of Sydney), Nic worked in a number of banks where he traded various portfolios. Since leaving that industry, Nic has developed specific expertise in the development industry as Director of Berambing Sustainable Developments.

Neill Miller

Neill is an advisory board member to Global Carbon Systems, the Chairman of Global Sustainability Investments and a Director of various property and technology businesses in Australia and the US.  Neill is a founder of Private Equity and Venture Capital where he has been building and selling successful businesses for over 40 years. With his first company listed on the Johannesburg Stock Exchange (JSE), Neill also facilitated several mergers and acquisitions, including companies such as Bell and Howell, Micrographix and Business Land. Neill was directly involved in the listing of 5 public companies on the JSE. After immigrating to Australia, he formed a start up computer software company System Builder Development Inc (SBD) and over the next 8 years built this into an international group consisting of several companies in multiple countries. In November 1995 SBD merged with a USA based Database Company (Unidata Inc). Neill was also the principal architect behind the merger of Unidata and a Nasdaq listed company (Vmark), which became Ardent Software – one of the top 100 computer companies in the world at that time. Ardent subsequently merged with Informix to create one of the top 5 largest database supply companies in the world and was ultimately acquired by IBM for over $2.5 billion.  Neill was an early investor in SEEK, PC Tools, NanoSonic, Beeologics and YBR.

Ben Peacock

Ben is a Founder and Partner at Republic of Everyone, a sustainable communications firm in Sydney.  Republic of Everyone engage global corporations and all levels of government to develop and deploy sustainable and green marketing strategies.  Ben is the recipient of NSW Government Department of Environment & Climate Change Green Globe Award for Excellence in Sustainability Communications 2009, is a Green Awards Finalist 2009 and took Best in Class, Interactive Media Awards 2009.  Ben can help you show the world that the grass is greener where you are standing.

Rui Rodrigues

Rui is a venture consultant, angel investor and high-octane engineer. After studying mechanical engineering in Portugal, Rui completed a MSc in France and an MBA at the London Business School. He is the former Technical and Commercialisation Director of the Portuguese Centre for Innovation and Creative Engineering, and was the Test Team Engine Chief Engineer for 7 years with the Lotus Renault Formula 1 Team. He also worked for a London-based venture capital fund, where he started investing in cleantech. Rui likes to get his hands dirty and work with crazy entrepreneurs to develop innovative businesses and technologies.

Tony Romagnino

Tony is currently a Director of TM Ventures, a boutique consulting company in the life sciences that provides integrated business development and commercialisation services.  Prior to this role, he was General Manager of Technology Commercialisation at University of New South Wales (UNSW), where his team quadrupled the licensing, research and commercial income at the university; closed one of the single, largest licensing deals in the history of UNSW; and managed 8 spin out companies.  Tony has proven experience in manufacturing, distribution and marketing in both the Australian and North American contexts.

Andrew Stead

Andrew is a co-founder of both Ignition Labs and Sydney Angels.  He is the Director of Business Development at ATP Innovations, Australia’s largest community of technology entrepreneurs and lectures in entrepreneurship at the University of Sydney.  Andrew adds successes like the sale of a search technology to Google to his 15 years experience in the global information technology and telecommunications sector. 
Andrew has a Bachelor of Science (Hons) from the University of Sydney, an MBA from the Macquarie Graduate School of Management, is a graduate of the Royal Military College Sandhurst, is a member of the Australian Institute of Company Directors (GAICD) and was awarded a Churchill Fellowship in 2009.

Andrew Tanner

Andrew is currently the Vice President of Engineering at Chromasun.  Chromasun is based in the San Francisco Bay Area, where they develop and manufacture the next generation of commercial/industrial sized solar collectors for building energy needs. Chromasun’s vision is to harvest solar energy for air-conditioning, power, process heat, and lighting, right on the roof.   Before Chromasun, Andrew was a Senior Engineer at Ausra.  Andrew has a bachelors degree in Econimics/Commerce, Mechanical Engineering and Business from the University of Sydney.

Melissa Widner

Melissa is a General Partner at SeaPoint Ventures, a US based venture capital firm focused on early stage technology investments. She is the cofounder of 7Software, an enterprise software company providing web based applications for corporate e-procurement. As CEO, Melissa managed the company from inception to a successful acquisition by Concur Technologies, Inc. (NASDAQ: CNQR), resulting in a 10X return to investors. Previously, Melissa was the CEO of Northwest Supply, an industrial products manufacturer and distributor, where she managed the company to an acquisition, resulting in a 15X return to investors. She was the founder and President of the Northwest Chapter of the Forum for Women Entrepreneurs and a member of the board of the Alliance of Angels. Melissa served as a lecturer at the University of Washington’s Graduate School of Business where she taught courses on venture capital and entrepreneurship. Melissa is a founding member of the Sydney Angels, a group focused on investments in early stage companies. She is an active angel investor, who has structured and led financing rounds for technology and consumer goods focused companies. Melissa served as a board director on several US based venture backed technology companies as well as a director on the University of Washington, Bothell’s Business School Advisory Board. Melissa holds a Masters degree from Stanford University and a Bachelor’s degree from the University of Washington. Melissa relocated to Sydney in 2009.

Ben Wright

Ben is the Director of Commercial Development at ATP Innovations.  He has worked in and on start-ups for more than 13 years and has extensive experience in Research and Development, Operations, Financial Management and Commercialisation within both private and ASX listed technology businesses.  Ben has a Bachelor of Science  (Biological Sciences) from the University of Western Sydney and undertook postgraduate Biomedical Engineering at the University of New South Wales.

Robert Wulff

Rob is a Principle at IP firm Griffith Hack.  After 23 years in intellectual property; 3 years in engineering and lecturing on intellectual property, Rob is the Group Leader for Engineering and the National Coordinator for Clean Technologies at Griffith Hack.  He was formerly the Chairman for Aionova, a complimentary medicines business and is now the Chairman of Ambercite, a patent analytics company that has applied network theory and the associated mathematical algorithms to large patent datasets to extract meaningful information.